Edwards Lifesciences to present at J.P. Morgan Healthcare Conference.

Edwards Lifesciences Corporation will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 14, 2025. Bernard Zovighian, CEO, and Scott Ullem, CFO, will present. The live webcast of the presentation will be available on Edwards' investor relations website, with an archived version accessible later the same day. Edwards Lifesciences is a leading global structural heart innovation company, driven by a passion to improve patient lives.

Edwards Lifesciences Corporation (NYSE: EW), a leading global structural heart innovation company, is set to participate in the highly anticipated 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. This esteemed event serves as a premier platform for companies to present their latest developments and future growth prospects to investors and industry experts.

Bernard Zovighian, the company's CEO, and Scott Ullem, CFO, will represent Edwards Lifesciences during the conference. The presentation, scheduled for 11:15 a.m. PT, will be accessible via a live webcast on the company's investor relations website (http://ir.edwards.com/). An archived version of the webcast will also be available later the same day for those unable to attend the live presentation.

Edwards Lifesciences is renowned for its commitment to improving patient lives through groundbreaking technologies and strategic partnerships with healthcare stakeholders. The company's portfolio includes a diverse range of products designed to address various structural heart conditions, such as transcatheter aortic valve replacement (TAVR) systems and surgical heart valves.

According to a press release by Business Wire ([1]), Edwards Lifesciences is the global leader in structural heart innovation. The company's focus on developing life-changing innovations has positioned it as a key player in the healthcare industry. StockTitan further emphasizes this by stating that Edwards Lifesciences is "dedicated to delivering breakthrough technologies and maintaining partnerships with healthcare stakeholders to improve patient lives" ([2]).

As the company prepares to present at the J.P. Morgan Healthcare Conference, investors and stakeholders alike are eagerly anticipating updates on Edwards Lifesciences' latest innovations, growth strategies, and future prospects. The live webcast presentation offers an excellent opportunity for attendees to gain valuable insights into the company's plans and vision for the future.

References:
[1] Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference. (2025, January 7). BusinessWire. Retrieved from https://www.businesswire.com/news/home/20250107783243/en/
[2] Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference. (2025, January 7). StockTitan. Retrieved from https://www.stocktitan.net/news/EW/edwards-lifesciences-to-present-at-the-43rd-annual-j-p-morgan-q9cn3ea7rb1z.html